These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 1392409)

  • 21. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK
    J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs for treatment of peptic ulcers.
    Dajani EZ; Trotman BW
    J Assoc Acad Minor Phys; 1992; 3(3):78-88. PubMed ID: 1353999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of NSAID-induced ulcer disease.
    Clearfield HR
    Am Fam Physician; 1992 Jan; 45(1):255-8. PubMed ID: 1728095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
    Koch M; Dezi A; Ferrario F; Capurso I
    Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Lad R; Armstrong D
    Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antisecretory drugs and prophylaxis of secondary gastrointestinal effects associated with the consumption of non steroid anti-inflammatory drugs].
    Lanas A; Arroyo MT
    Med Clin (Barc); 2000; 114 Suppl 2():57-62. PubMed ID: 10916808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-steroidal anti-inflammatory drug-induced gastroduodenal injury: therapeutic recommendations.
    Curtis WD; Griffin JW
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():99-109. PubMed ID: 1679675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptic ulcers in the elderly: unique features and management.
    Freston MS; Freston JW
    Geriatrics; 1990 Jan; 45(1):39-42, 45. PubMed ID: 2403956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in managing NSAID-associated gastrointestinal tract injury.
    Goldstein JL
    Digestion; 2004; 69 Suppl 1():25-33. PubMed ID: 15001832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms.
    Laine L
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S30-9. PubMed ID: 14671512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Misoprostol in the prevention of gastric erosions caused by nonsteroidal anti-inflammatory agents].
    Delmas PD; Lambert R; Capron MH
    Rev Rhum Ed Fr; 1994 Feb; 61(2):126-31. PubMed ID: 7920500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevention of chronic NSAID induced upper gastrointestinal toxicity: a Cochrane collaboration metaanalysis of randomized controlled trials.
    Rostom A; Wells G; Tugwell P; Welch V; Dubé C; McGowan J
    J Rheumatol; 2000 Sep; 27(9):2203-14. PubMed ID: 10990235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Scheiman JM
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of nonsteroidal anti-inflammatory drug-associated gastric and duodenal damage. Efficacy of antisecretory drugs and mucosal protective compounds.
    Pipkin G; Mills JG
    Dig Dis; 1995 Jan; 13 Suppl 1():75-88. PubMed ID: 7697904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy of prostaglandin derivatives and mucoprotective drugs in treatment and prevention for NSAIDs-induced ulcer].
    Fujikawa Y; Watanabe T; Tominaga K; Fujiwara Y; Sato H; Arakawa T
    Nihon Rinsho; 2011 Jun; 69(6):1039-43. PubMed ID: 21688624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoprotection with misoprostol: use in the treatment and prevention of ulcers.
    Ballinger A
    Dig Dis; 1994; 12(1):37-45. PubMed ID: 8200123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.